Iovance Biotherapeutics, Inc. (LON:0JDK)
London
· Delayed Price · Currency is GBP · Price in USD 5.77
+0.19 (3.45%)
At close: Feb 21, 2025
Iovance Biotherapeutics Market Cap
Iovance Biotherapeutics has a market cap or net worth of 1.39 billion as of February 21, 2025. Its market cap has decreased by -16.01% in one year.
Market Cap
1.39B
Enterprise Value
1.14B
Revenue
67.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.77
Market Cap Chart
Since May 26, 2010, Iovance Biotherapeutics's market cap has increased from 62.39M to 1.39B, an increase of 2,133.67%. That is a compound annual growth rate of 23.43%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 179.71B |
| GSK plc | 59.06B |
| Haleon | 34.94B |
| Smith & Nephew | 8.87B |
| Hikma Pharmaceuticals | 5.06B |
| ConvaTec Group | 4.94B |
| HUTCHMED (China) | 2.06B |
| Oxford Nanopore Technologies | 1.26B |